Genpact Ltd
NYSE:G
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genpact Ltd
NYSE:G
|
BM |
|
Spectral Medical Inc
TSX:EDT
|
CA |
|
Research Solutions Inc
F:61I
|
US |
|
A
|
American Express Co
SWB:AEC1
|
US |
|
Tilaknagar Industries Ltd
NSE:TI
|
IN |
|
Blue Bird Corp
F:4RB
|
US |
Wall St Price Targets
G Price Targets Summary
Genpact Ltd
According to Wall Street analysts, the average 1-year price target for
G is 43.24 USD with a low forecast of 32.32 USD and a high forecast of 60.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G's stock price target?
Price Target
43.24
USD
According to Wall Street analysts, the average 1-year price target for
G is 43.24 USD with a low forecast of 32.32 USD and a high forecast of 60.9 USD.
What is the Revenue forecast for Genpact Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Genpact Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for Genpact Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Genpact Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for Genpact Ltd?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 16%.